Icosa Europe competitive analysis

Loading summary...

Explore patent oppositions filed by Icosa Europe against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In TherapyPLURISTEMOct 1, 2020
Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila BacteriaMD HEALTHCAREDec 13, 2019

Latest publications and patents of Icosa Europe New

Explore the latest publications and patents granted to Icosa Europe, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Icosa Europe

Discover the latest PTAB cases involving Icosa Europe, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Icosa Europe with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ICOSA EUROPE2 - - -
MD HEALTHCARE - 1 - -
PLURISTEM - 3 - -